UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549
FORM 8-K
CURRENT REPORT PURSUANT
TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
Date of report (Date of earliest event reported): June 17, 2011
BIO-PATH HOLDINGS, INC.
(Exact name of registrant as specified in its charter)
|
Utah
|
000-53404
|
87-0652870
|
|
(State or other jurisdiction
of incorporation)
|
(Commission File Number)
|
(IRS Employer Identification No.)
|
|
3293 Harrison Blvd., Ste. 220, Ogden, UT
|
84403
|
|
(Address of principal executive offices)
|
(Zip Code)
|
801-580-2326
(Registrant’s Telephone Number, Including Area Code)
(Former Name or Former Address, if Changed Since Last Report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
¨ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Item 7.01 Regulation FD Disclosure.
The information in this Current Report is being furnished pursuant to Item 7.01 of Form 8-K and, according to general instruction B.2. thereunder, the information in this Current Report shall not be deemed “filed” for the purposes of Section 18 of the Securities Exchange Act of 1934 or otherwise subject to the liabilities of that Section. The information in this Current Report shall not be incorporated by reference into any registration statement pursuant to the Securities Act of 1933.
On June 17, 2011, Bio-Path Holdings, Inc. (the “Company”) announced that Peter Nielsen, President and Chief Executive Officer of the Company, will present an overview of the Company at the OneMedForum NY Conference in New York City on Thursday, June 23, 2011 at 12:00 p.m. Eastern Time.
A webcast of Mr. Nielsen’s remarks will be available live. To access the webcast, log onto www.onemedplace.com.
A copy of the Company’s press release is attached hereto as Exhibit 99.1. The foregoing description of the press release is qualified in its entirety by reference to the attached exhibit.
Item 9.01 Financial Statements and Exhibits.
(d) Exhibits.
|
Exhibit
Number
|
|
Description
|
| |
|
|
|
99.1
|
|
Press Release dated June 17, 2011
|
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| |
BIO-PATH HOLDINGS, INC. |
| |
|
|
|
Dated: June 17, 2011
|
By:
|
/s/ Peter H. Nielsen
|
| |
|
Peter H. Nielsen
|
| |
|
President and Chief Executive Officer
|
EXHIBIT INDEX
|
Exhibit
Number
|
|
Description
|
|
99.1
|
|
Press Release dated June 17, 2011
|